lorlatinib
SpainDrugs containing this active substance
-
It is used to treat adults with a type of advanced lung cancer called non-small cell lung cancer (NSCLC), provided the disease is positive for the ALK gene alteration.
Form: tablets, film-coated
Active substance Dosage lorlatinib 100 mg Manufacturer: Pfizer Europe Ma Eeig
-
It is used to treat adults with a type of advanced lung cancer called non-small cell lung cancer (NSCLC), provided it is ALK-positive.
Form: tablets, film-coated
Active substance Dosage lorlatinib 25 mg Manufacturer: Pfizer Europe Ma Eeig